{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T08:01:02Z","timestamp":1761292862344},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Chin. J. Integr. Med."],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1007\/s11655-011-0894-9","type":"journal-article","created":{"date-parts":[[2011,11,5]],"date-time":"2011-11-05T13:17:58Z","timestamp":1320499078000},"page":"834-839","source":"Crossref","is-referenced-by-count":20,"title":["Clinical observation of the treatment of myelodysplastic syndrome mainly with Qinghuang Powder (\u9752\u9ec4\u6563)"],"prefix":"10.1007","volume":"17","author":[{"given":"Shu","family":"Xu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rou","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-mei","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong-gang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-hong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong-zhi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shu-zhen","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,11,6]]},"reference":[{"key":"894_CR1","first-page":"216","volume":"28","author":"S. Xu","year":"2008","unstructured":"Xu S, Hu XM, Xu YG. Effect of treatment for myelodysplastic syndrome by Qinghuang Powder combined with Chinese herbs for reinforcing Shen and strengthening Pi. Chin J Integr Tradit West Med (Chin) 2008;28:216\u2013219.","journal-title":"Chin J Integr Tradit West Med (Chin)"},{"key":"894_CR2","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1365-2141.1982.tb08475.x","volume":"51","author":"J.M. Bennett","year":"1982","unstructured":"Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR, et al. Proposals for the classification of the myelodysplastic syndromes. Br J Haematol 1982;51:189\u2013199.","journal-title":"Br J Haematol"},{"key":"894_CR3","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1182\/blood.V89.6.2079","volume":"89","author":"P. Greenberg","year":"1997","unstructured":"Greenberg P, Cox C, LeBeau MM, Fenaux P, Morel P, Sanz G, et al. International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood 1997;89:2079\u20132088.","journal-title":"Blood"},{"key":"894_CR4","volume-title":"An international system for human cytogenetic nomenclature","author":"F. Mitelman","year":"1995","unstructured":"Mitelman F. ISCN (1995). An international system for human cytogenetic nomenclature. Basel, Swizeland: S. Karger; 1995."},{"key":"894_CR5","first-page":"3671","volume":"96","author":"B.D. Cheson","year":"2000","unstructured":"Cheson BD, Bennett JM, Kantarjian H, Pinto A, Schiffer CA, Nimer SD, et al. Report of an international working group to standardize response criteria for myelodysplastic syndromes. Blood 2000;96:3671\u20133674.","journal-title":"Blood"},{"key":"894_CR6","doi-asserted-by":"crossref","unstructured":"William Blum. How much? How frequent? How long? A clinical guide to new therapies in myelodysplastic syndromes. Hematol Am Soc Hematol Educ Program 2010:314-321.","DOI":"10.1182\/asheducation-2010.1.314"},{"key":"894_CR7","doi-asserted-by":"crossref","first-page":"4385","DOI":"10.1182\/blood-2007-03-082404","volume":"110","author":"D. Haase","year":"2007","unstructured":"Haase D, Germing U, Schanz J, Pfeilstocker M, Nosslinger T, Hildebrandt B, et al. New insights into the prognostic impact of the karyotype in MDS and correlation with subtypes: evidence from a core dataset of 2124 patients. Blood 2007;110:4385\u20134395.","journal-title":"Blood"},{"key":"894_CR8","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/S0145-2126(00)00088-6","volume":"25","author":"U. Germing","year":"2000","unstructured":"Germing U, Gattemann N, Strupp C, Aivado M, Aul C. Validation of the WHO proposal for a new classifications of primary myelodysplastic syndromes: a retrospective analysis of 1 600 patients. Leukemia Res 2000;25:983\u2013993.","journal-title":"Leukemia Res"},{"key":"894_CR9","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/BF01700373","volume":"70","author":"D. Haase","year":"1995","unstructured":"Haase D, Fonatsch C, Freund M, W\u00f6rmann B, Bodenstein H, Bartels H, et al. Cytogenetic findings in 179 patients with myelodysplastic syndromes. Ann Hematol 1995;70:171\u2013178.","journal-title":"Ann Hematol"},{"key":"894_CR10","first-page":"262","volume":"19","author":"R. Ma","year":"2010","unstructured":"Ma R, Hu XM. Treatment focused on myelodysplastic syndromes based on cytogenetic categories. J Leukemia Lymphoma (Chin) 2010;19:262\u2013264.","journal-title":"J Leukemia Lymphoma (Chin)"},{"key":"894_CR11","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1182\/blood.V88.3.1052.1052","volume":"88","author":"G.Q. Chen","year":"1996","unstructured":"Chen GQ, Zhu J, Shi X G, Ni JH, Zhong HJ, Si GY, et al. In vitro studies on cellular and molecular mechanisms of arsenic troxide (As2O3) in the treatment of acute promyelocytic leukemia: As2O3 induces NB4 cell apoptosis with down regulation of Bcl-2 expression and modulation of PML-RAR\u03b1\/PML proteins. Blood 1996;88:1052.","journal-title":"Blood"},{"key":"894_CR12","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1053\/shem.2001.20863","volume":"38","author":"Z. Chen","year":"2001","unstructured":"Chen Z, Chen GQ, Shen ZX, Chen SJ, Wang ZY. Treatment of acute leukemia with arsenic compounds: in vitro and in vivo studies. Semin Hematol 2001;38:26.","journal-title":"Semin Hematol"},{"key":"894_CR13","volume-title":"The clinical study of combinative treatment of Huayu Bushen method with androgen in myelodysplastic syndromes","author":"S. Xu","year":"2004","unstructured":"Xu S. The clinical study of combinative treatment of Huayu Bushen method with androgen in myelodysplastic syndromes. Beijing: Doctoral Dissertation of China Academy of Chinese Medical Sciences; 2004."},{"key":"894_CR14","first-page":"596","volume":"25","author":"S. Xu","year":"2009","unstructured":"Xu S, Xu YG, Yang XH, Hu XM, Wang HZ, Liu F, et al. Analysis of the quantity and function of innate immunologic cell in patients of myelodysplatic syndrome (MDS). Chin J Immun (Chin) 2009;25:596\u2013600.","journal-title":"Chin J Immun (Chin)"}],"container-title":["Chinese Journal of Integrative Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11655-011-0894-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11655-011-0894-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11655-011-0894-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,27]],"date-time":"2020-06-27T04:10:21Z","timestamp":1593231021000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11655-011-0894-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11]]},"references-count":14,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2011,11]]}},"alternative-id":["894"],"URL":"https:\/\/doi.org\/10.1007\/s11655-011-0894-9","relation":{},"ISSN":["1672-0415","1993-0402"],"issn-type":[{"value":"1672-0415","type":"print"},{"value":"1993-0402","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,11]]}}}